Paxlovid, the on-patent, antiviral drug Pfizer fast-tracked for COVID-19 early treatment after a year of insisting there was no reliable early treatment for COVID-19, has been getting some marketing attention recently.
A retired surgeon contracted COVID, but was prepared with his "Just-in-Case kit." He also tested ivermectin and Paxlovid on himself.
On The HighWire with Del Bigtree, Dr. Pierre Kory didn’t hold back when speaking about the brand $panking new “anti-viral” Paxlovid.
Paxlovid: A Guide to Making an Informed Decision - This Q&A from the Canadian COVID Care Alliance answers a number of targeted questions to better understand the oral antiviral medication currently being offered for COVID treatment.
By mentioning a Pfizer drug by name in his State of the Union Address, Biden showed the clear bias this government has for expensive, high-profit drugs while ignoring lower-cost treatments.
NewsConcerns explains that Molnupiravir, Merck’s new anti-viral, has issues with both efficacy and safety.
FLCCC founder and Chief Medical Officer, Dr. Pierre Kory, talked to Eric Bolling on The Balance and compared Merck's "COVID pill" to ivermectin.